These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30788495)

  • 21. Gastrointestinal Stromal Tumors Risk Stratification Utilizing Phospho-Histone H3 Evaluated by Manual Counting and Computer-Assisted Image Analysis.
    Jin C; Huang Y; Nasim M; Yang Y; Lee L
    Int J Surg Pathol; 2019 Oct; 27(7):706-712. PubMed ID: 31146625
    [No Abstract]   [Full Text] [Related]  

  • 22. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
    Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
    Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
    Solomides CC; Birbe RC; Nicolaou N; Bagley D; Bibbo M
    Acta Cytol; 2012; 56(3):285-8. PubMed ID: 22555531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.
    Kim YJ; Ketter R; Steudel WI; Feiden W
    Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
    Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P
    Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiency.
    Laflamme P; Mansoori BK; Sazanova O; Orain M; Couture C; Simard S; Trahan S; Manem V; Joubert P
    Hum Pathol; 2020 Dec; 106():74-81. PubMed ID: 33007357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index.
    Sun W; Caraway NP; Zhang HZ; Khanna A; Payne LG; Katz RL
    Acta Cytol; 2004; 48(2):119-26. PubMed ID: 15085740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry.
    Martinez AE; Lin L; Dunphy CH
    Arch Pathol Lab Med; 2007 Jul; 131(7):1084-8. PubMed ID: 17616995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.
    Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K
    Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningiomas: Objective assessment of proliferative indices by immunohistochemistry and automated counting method.
    Chavali P; Uppin MS; Uppin SG; Challa S
    Neurol India; 2017; 65(6):1345-1349. PubMed ID: 29133712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphohistone H3 and Ki-67 labeling indices in cytologic specimens from well-differentiated neuroendocrine tumors of the gastrointestinal tract and pancreas: a comparative analysis using automated image cytometry.
    Fung AD; Cohen C; Kavuri S; Lawson D; Gao X; Reid MD
    Acta Cytol; 2013; 57(5):501-8. PubMed ID: 24021213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
    Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC
    Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.
    Aune G; Stunes AK; Tingulstad S; Salvesen O; Syversen U; Torp SH
    Int J Clin Exp Pathol; 2011 Jun; 4(5):444-53. PubMed ID: 21738816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical results obtained with Ki67-labeling and PHH3-mitosis index in glial tumors: a literature analysis.
    Elmaci İ; Altinoz MA; Bolukbasi FH; Yapicier O; Sav A
    Clin Neuropathol; 2017; 36(6):272-282. PubMed ID: 28853695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
    Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
    Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
    Murphy CE; McCormick KA; Shankaran V; Reddi DM; Swanson PE; Upton MP; Papanicolau-Sengos A; Khor S; Westerhoff M
    Pancreas; 2017; 46(10):1359-1365. PubMed ID: 29040195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EPIGENETIC CHANGES - HISTONE 3 PHOSPHORYLATION - EPITHELIAL OVARIAN TUMORS.
    Munjishvili V; Barabadze E; Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2019 Sep; (294):128-131. PubMed ID: 31687964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
    Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA
    Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.